US equities |
NVDA $237.26 ▲+1.41% MU $1,057.35 ▼-1.63% SPCX $163.72 ▲+3.00% MSFT $529.02 ▲+2.22% TSLA $373.38 ▲+0.75% INTC $117.22 ▼-1.76% SNDK $1,725.64 ▲+0.33% AMD $630.04 ▼-0.61%
FinancialContent

Articles published by PerkinElmer, Inc.

< Previous 1 2 Next >
News headline image
PerkinElmer Board Declares Quarterly Dividend
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Completes Divestiture of its Applied, Food and Enterprise Services Businesses
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Launches EnVison Nexus Multimode Plate Reader to Drive Improved Research and Discovery Workflows
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer to Present at Upcoming Investor Conferences
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Board Declares Quarterly Dividend
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Announces Financial Results for the Third Quarter of 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Board Declares Quarterly Dividend
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer to Hold Earnings Call on Tuesday, November 8, 2022; Updates Third Quarter Outlook
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Unveils Industry-first Cell Analysis Solution to Streamline Cell and Gene Therapy Research and Manufacturing
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Announces Finance Leadership Transition
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Announces Financial Results for the Second Quarter of 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Accelerates Transformation into High Growth, High Margin Life Sciences & Diagnostics Company
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Board Declares Quarterly Dividend
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Elects Dr. Michelle McMurry-Heath to its Board of Directors
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Schedules Earnings Call for Thursday, August 4, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Introduces Next Generation, Automated Gas Chromatography Platform
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Expands Food Safety Testing Portfolio with AOAC Certified Microbial Count Plates
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer Launches BioQule NGS System to Automate Library Preparation
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer Announces Financial Results for the First Quarter of 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Board Declares Quarterly Dividend
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Schedules Earnings Call for Tuesday, May 3, 2022
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Expands In Vivo Instruments Portfolio with Hands-free, High-throughput Vega® Widefield Preclinical Ultrasound Imaging System
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Introduces First Ready-to-use HTRF® and AlphaLISA® Assay Kits for CHO HCP Impurities Detection and Quantification
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer’s SIRION Biotech Teams with Centre for Genomic Regulation to Develop New Generation AAV Vectors for Type 1 and Type 2 Diabetes Gene Therapy
From PerkinElmer, Inc.
Via Business Wire
News headline image
PerkinElmer to Present at Citi’s 2022 Virtual Healthcare Conference
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
U.S. Centers for Disease Control Guidance Includes EUROIMMUN Assay in its Two-Step Testing Algorithm for Dengue Virus
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
News headline image
PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year of 2021
From PerkinElmer, Inc.
Via Business Wire
Tickers PKI
< Previous 1 2 Next >